Product Description
The Infant Phototherapy Unit Model YR06219 stands as a pioneering solution in neonatal jaundice management. Engineered to deliver effective phototherapy treatment, this model utilizes a blue tube light source which ensures a wavelength range of 400-550nm, optimal for reducing bilirubin levels in infants. A standout feature of this unit is its efficient power consumption, operating at less than 150VA, making it both energy-efficient and cost-effective for healthcare facilities.
One of the remarkable aspects of the YR06219 is its capability to deliver consistent performance with a light source life of 1000 hours. This durability translates into less frequent replacements and maintenance, thereby enhancing its practicality and economic viability. The phototherapy unit boasts an irradiance treatment distance ranging from 10~500px, and covers an effective area of 1125px×600px, effectively accommodating different treatment requirements.
The design also places significant emphasis on patient safety. With infrared radiation in the effective area maintained at ≤10mW/cm² for wavelengths between 760nm and 1400nm, and ultraviolet radiation controlled at ≤1.0×10-5mW/cm² for wavelengths between 180nm and 400nm, the unit minimizes thermal and UV exposure risks. Noise control is another key feature, as the unit operates at ≤55dB(A), ensuring a quiet environment conducive for both infants and healthcare providers. The YR06219 offers a basic performance of ≥500μW/cm², delivering reliable and intensive phototherapy that meets clinical expectations.
| Model | YR06219 |
| Input power | <150VA |
| Light source | Blue tube |
| Light source effective life | 1000 hours |
| Wave length | 400-550nm |
| Irradiance treatment distance | 10~500px |
| Effective area | 1125px×600px |
| Infrared radiation in effective area | ≤10mW/cm²(760nm<λ≤1400nm) |
| Ultraviolet radiation in effective area | ≤1.0×10-5mW/cm² (180nm<λ≤400nm) |
| Operate noise | ≤55dB(A)(ambit noise is lower than 40dB(A)) |
| Basic performance | ≥500μW/cm² |
Market Price
The market for infant phototherapy units is diverse, but the Model YR06219 stands out for its blend of advanced technology and affordability. Typically, such units are priced between 500 USD and 800 USD, varying based on the supplier and additional features that might be included. Within this range, the YR06219 presents a competitive advantage, offering cutting-edge functionality and robust performance at a very market-friendly price.
For those interested in acquiring the Infant Phototherapy Unit YR06219, requesting a quote or generating an automated quote via the Kalstein Plus platform can provide precise pricing adapted to specific needs and procurement conditions.
Frequently Asked Questions
What makes the YR06219 model different from other phototherapy units?
This model combines energy efficiency with advanced performance features like long-lasting light sources, optimal wavelength range, and safety measures against over-exposure to infrared and ultraviolet radiation, all focused on improving neonatal healthcare.
Is the YR06219 suitable for all neonatal patients?
Yes, the YR06219 is designed to cater to a wide range of neonatal patients struggling with jaundice, ensuring effective treatment through adjustable irradiance and coverage area.
How often should the light source be replaced?
The light source in the YR06219 is built to last up to 1000 hours under optimal conditions, reducing the frequency of replacements and ensuring consistent performance.
Advantages and Disadvantages
One of the primary advantages of the YR06219 phototherapy unit is its efficiency and reduced energy consumption. It offers sustained light intensity with minimal power input, keeping operational costs low. The durable light source also means decreased maintenance requirements and longer intervals between part replacements.
On the downside, the fixed blue tube light technology, while effective, might not cater to situations where variable light intensities or broader spectrum sources are necessary. Moreover, while noise levels are maintained at a minimum, settings requiring absolute silence might need additional measures.
Usage in the Field
In practice, the YR06219 is widely adopted in neonatal care units across hospitals and clinics, equipped to handle infants with jaundice by lowering bilirubin levels through phototherapy. Its ergonomic design ensures that it fits seamlessly within healthcare environments, enabling easy positioning over neonatal beds and incubators to maximize treatment effectiveness.
The unit’s design facilitates easy adjustments in both gurney and light source height, allowing healthcare providers to tailor the phototherapy treatment based on the infant’s needs. Additionally, its portability ensures ease of movement across different medical settings.
Recommendations
To maximize the efficacy of the YR06219, it is essential to regularly monitor the operational hours of the light source and plan for timely replacements to prevent service interruptions. Maintaining the unit clean, especially the light source cover and surroundings, will ensure optimal light delivery and hygiene standards.
Training healthcare personnel to adjust the device correctly and monitor irradiance exposure can significantly enhance treatment outcomes. Regular updates on the usage protocols will help keep the medical team informed about the best practices in phototherapy administration.
If you’re seeking a blend of innovation and quality, you’ve come to the right place. At Kalstein, we invite you to explore our exclusive catalog of laboratory equipment. We manufacture each piece with a level of excellence. Our intuitive and fast online purchasing channels are designed for your convenience, ensuring the most friendly prices. Don’t wait any longer, we bring science to life, it’s time to join our community. https://kalstein.net/en/product/infant-phototherapy-unit-yr06219/.
